Elevated acute phase proteins affect pharmacokinetics in COVID‐19 trials: Lessons from the Counte...
This study aimed to determine whether published pharmacokinetic (PK) models can adequately predict the PK profile of imatinib in a new indication, such as coronavirus disease 2019 (COVID-19). Total...
ascpt.onlinelibrary.wiley.com